Clinical trials: Functional Dyspepsia
Dyspepsia, Functional Dyspepsia
A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia
To examine the safety and efficacy of Z-338 (YM443) after long-term administration in patients with functional dyspepsia, and also to examine the pattern of long-term administration.
- Trial name
- NCT00764374
- Testing
- YM443
- Where
- 4 sites in Japan
- Volunteers
- 412 people
- Sponsor
- Astellas Pharma Inc
Dyspepsia, Functional Gastrointestinal Disorders
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
The objectives of this study are to determine the safety and efficacy of IW-9179 administered to patients with functional dyspepsia (FD).
- Trial name
- NCT01712412
- Testing
- IW-9179
- Where
- 15 sites in Belgium, Netherlands
- Volunteers
- 10 people
- Sponsor
- Ironwood Pharmaceuticals, Inc.
Functional Dyspepsia
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia
The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.
- Trial name
- NCT03024086
- Testing
- DWJ1252, Gasmotin
- Where
- South Korea
- Volunteers
- 124 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Functional Dyspepsia
A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204)
The purpose of this study is to assess the efficacy and safety of rabeprazole compared to placebo in Japanese subjects with Functional Dyspepsia.
- Trial name
- NCT01089543
- Testing
- Rabeprazole
- Where
- 46 sites in Japan
- Volunteers
- 338 people
- Sponsor
- Eisai Co., Ltd.
Functional Dyspepsia
A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
This is a multicenter, randomized, double-blind, placebo-controlled dose-finding phase 2 trial to evaluate the efficacy and safety of YH12852 in patients with functional dyspepsia.
- Trial name
- NCT02567578
- Testing
- YH12852 0.1 mg, YH12852 0.25 mg, YH12852 0.5 mg
- Where
- South Korea
- Volunteers
- 12 people
- Sponsor
- Yuhan Corporation
Functional Dyspepsia
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)
The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia.
- Trial name
- NCT03184402
- Testing
- DWJ1252, Gasmotin
- Where
- South Korea
- Volunteers
- 124 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Nonulcer Dyspepsia
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
This study was designed is to examine the idea that GW679769 has an effect on three of the pathophysiological disturbances reported in patients with Functional Dyspepsia (FD): impaired stomach accommodation to a meal, delayed…
- Trial name
- NCT00358410
- Testing
- GW679769 oral tablets
- Where
- Belgium
- Volunteers
- 13 people
- Sponsor
- GlaxoSmithKline
Functional and Motility Related Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia
A Pharmacy-based Study to Learn More About How Well Iberogast Works, How it Affects the Body, How it is Used, and User Satisfaction in Patients With Functional and Motility-related (Stomach and Bowel Movement-related) Gastrointestinal Diseases, Including Irritable Bowel Syndrome
Researchers want to learn more about the day-to-day use of Iberogast in people who have functional and motility-related gastrointestinal (stomach and bowel) diseases.
- Trial name
- NCT04993989
- Testing
- Iberogast (STW5, BAY98-7411)
- Where
- Germany
- Volunteers
- 843 people
- Sponsor
- Bayer
Functional Dyspepsia
Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients
The purpose of this study is to evaluate the safety and validity of Aolanti Weipang Tablets in Patients with Postprandial Discomfort Syndrome of Functional Dyspepsia
- Trial name
- NCT03971383
- Testing
- Aolanti Weipang Tablets
- Where
- China
- Volunteers
- 236 people
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Functional Dyspepsia
A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia
This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia
- Trial name
- NCT07686679
- Testing
- DA-9701, DA-9701-R
- Where
- South Korea
- Volunteers
- 300 people
- Sponsor
- Dong-A ST Co., Ltd.
Functional Dyspepsia
Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia
This study is a multi-center, randomized, active-controlled, double-blind, non-inferiority, phase III clinical trial evaluating efficacy and safety of once-daily mosapride (UI05MSP015CT) in patients with functional dyspepsia.
- Trial name
- NCT03225248
- Testing
- UI05MSP015CT, Gasmotin
- Volunteers
- 143 people
- Sponsor
- Korea United Pharm. Inc.
Functional Gastrointestinal Disorders, Abdominal Pain
Pepsin in Patients With Functional Dyspepsia
This non-interventional, observational study investigates the course of symptoms in patients with functional dyspepsia under treatment with a fixed combination of pepsin and amino acid hydrochloride over a period of approximately…
- Conditions
- Functional Gastrointestinal Disorders, Abdominal Pain, Dyspepsia, Nausea
- Trial name
- NCT03076411
- Testing
- Pepsin
- Where
- Germany
- Volunteers
- 97 people
- Sponsor
- Nordmark Arzneimittel GmbH & Co. KG
Dyspepsia
The Effects of Z-338 in Subjects With and Without Functional Dyspepsia
To assess in subjects with and without functional dyspepsia the effects of Z-338 on: 1. Type and severity of symptoms a standardized nutrient challenge 2.
- Trial name
- NCT00298194
- Testing
- Z-338
- Where
- Australia
- Volunteers
- 52 people, healthy volunteers welcome
- Sponsor
- Zeria Pharmaceutical
Functional Dyspepsia
Probiotic and Ginger Supplement for Symptoms and Quality of Life in Functional Dyspepsia (SUBTILE)
Functional dyspepsia (FD) is a frequent functional gastrointestinal disorder characterized by bothersome postprandial fullness, early satiety, epigastric pain, or burning, in the absence of any structural or metabolic cause.
- Trial name
- SUBTILE (NCT07212907)
- Testing
- Symbiosys® Stomalex (commercial name)
- Where
- France
- Volunteers
- 198 people
- Sponsor
- Biocodex
Functional Dyspepsia
Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia
The aim of this study is to show non-inferiority of two brands of simeticone in adult patients suffering from functional dyspepsia.
- Trial name
- NCT02660372
- Testing
- Imonogas, Espumisan
- Where
- Russia
- Volunteers
- 210 people
- Sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide
Postprandial Distress Syndrome
Acotiamide vs Itopride in Postprandial Distress Syndrome
The goal of this study is to "To compare the efficacy and safety of Acotiamide versus Itopride in patient with post prandial distress syndrome type of functional dyspepsia"
- Trial name
- NCT07174297
- Testing
- Acotiamide
- Volunteers
- 152 people
- Sponsor
- Getz Pharma
Functional Dyspepsia
Study of Aolanti Weikang Tablets in Healthy Volunteers
The purpose of this study is to evaluate the safety and tolerability of multiple doses escalation of Aolanti Weikang tablets to determine the MTD in healthy volunteers
- Trial name
- NCT03358485
- Testing
- Aolanti Weikang tablets
- Where
- China
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Dyspepsia
Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients
Purpose of the study: To obtain additional data on efficacy and safety of Kolofort in the treatment of patients with functional dyspepsia.
- Trial name
- NCT03119766
- Testing
- Kolofort
- Where
- 32 sites in Russia
- Volunteers
- 370 people
- Sponsor
- Materia Medica Holding
Dyspepsia, Irritable Bowel Syndrome
A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G
A randomized, sham-controlled, single-centre pilot investigation designed to compare two parallel groups, gammaCore®-G (active treatment) and a sham, (inactive) treatment in subjects with FGIDs.
- Trial name
- NCT02388269
- Testing
- gammaCore®-G
- Where
- United Kingdom
- Volunteers
- 91 people
- Sponsor
- ElectroCore INC
Functional Dyspepsia
Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia
The study is conducted in patients with functional dyspepsia or chronic gastritis. The purpose of this study is to: assess whether the dose of Itopride Hydrochloride 150 mg extended release tablets, taken once daily has a similar…
- Trial name
- NCT06217393
- Testing
- Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets
- Where
- 19 sites in Armenia, Malaysia and 3 more
- Volunteers
- 564 people
- Sponsor
- Abbott